On November 11, Brazilian agency ANVISA published Public Consultations (Consultas Públicas)nº 938-960 on the following active ingredients: 2.4-D, acetamiprid, acibenzolar-s-m, alpha-cypermethrin, azoxystrobin, chlorantraniliprole/rynaxypyr, chlorothalonil, chlorpyrifos, cyazofamid, cyprodinil, difenoconazole, dinotefuran, flubendiamide, glyphosate, mandipropamid, melaleuca alternifolia, metalaxyl-m, sulfoxaflor/isoclast and trinexapac-e
These proposed MRLs are already loaded into the Homologa™ database.
For more information please contact us.
